Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia. (Q54643257)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia. (English)

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

author name string

S Mizuta

1

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

F Yagasaki

3

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

T Yujiri

4

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

Y Hatta

5

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

Y Kimura

6

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

Y Ueda

7

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

H Kanamori

8

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

N Usui

9

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

H Akiyama

10

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

Y Miyazaki

11

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

S Ohtake

12

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

Y Atsuta

13

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

H Sakamaki

14

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

K Kawa

15

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

Y Morishima

16

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

K Ohnishi

17

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

T Naoe

18

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

R Ohno

19

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

publication date

14 October 2010

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

25

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

1

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

41-47

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

https://scigraph.springernature.com/pub.10.1038/leu.2010.228

0 references

Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

Recent approaches in acute lymphoblastic leukemia in adults

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

Treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

The Japan Marrow Donor Program, the Japan Cord Blood Bank Network and the Asia Blood and Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

A Proportional Hazards Model for the Subdistribution of a Competing Risk

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

First-line treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in adults.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

Bone marrow transplant in Ph+ ALL patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

21 January 2018

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

7 January 2021

based on heuristic

inferred from DOI database lookup

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing paradigm of the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.228

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2010.228

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20944676

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54643257&oldid=1500703406"